Kalmar “Rapamycin ba zai iya shiga kwakwalwa ba” ta zama ruwan dare a tsakanin masu sha'awar tsawaita rai. Binciken sabo a mujallar *Journal of Alzheimer's Disease* ya nuna cewa hujjar da ke goyon bayan wannan maganar tana dogara ne kan hanyar gwaji marar inganci, kuma ƙarin shaidu na nuni da akasin haka. Wannan labarin yana tantance hujjojin da ke tallafawa, waɗanda ba su tallafawa ba, da kuma abin da masana ke bukatar su bincika a gaba.
This page is available in